A Prodromal Brain-Clinical Pattern of Cognition in Synucleinopathies.

Annals of Neurology
Shady RahayelJean-François Gagnon

Abstract

Isolated (or idiopathic) rapid eye movement sleep behavior disorder (iRBD) is associated with dementia with Lewy bodies (DLB) and Parkinson's disease (PD). Biomarkers are lacking to predict conversion to a dementia or a motor-first phenotype. Here, we aimed at identifying a brain-clinical signature that predicts dementia in iRBD. A brain-clinical signature was identified in 48 patients with polysomnography-confirmed iRBD using partial least squares between brain deformation and 27 clinical variables. The resulting variable was applied to 78 patients with iRBD followed longitudinally to predict conversion to a synucleinopathy, specifically DLB. The deformation scores from patients with iRBD were compared with 207 patients with PD, DLB, or prodromal DLB to assess if scores were higher in DLB compared to PD. One latent variable explained 31% of the brain-clinical covariance in iRBD, combining cortical and subcortical deformation and subarachnoid/ventricular expansion to cognitive and motor variables. The deformation score of this signature predicted conversion to a synucleinopathy in iRBD (p = 0.036, odds ratio [OR] = 2.249; 95% confidence interval [CI] = 1.053-4.803), specifically to DLB (OR = 4.754; 95% CI = 1.283-17.618, p = 0....Continue Reading

References

Oct 21, 2000·The British Journal of Psychiatry : the Journal of Mental Science·M P WalkerC G Ballard
Dec 25, 2002·Neurobiology of Aging·Heiko BraakEva Braak
Sep 29, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Gregor K WenningUNKNOWN Multiple System Atrophy Study Group
Oct 27, 2004·NeuroImage·Anthony Randal McIntosh, Nancy J Lobaugh
Apr 9, 2005·Journal of the American Geriatrics Society·Ziad S NasreddineHoward Chertkow
Jun 16, 2005·NeuroImage·John Ashburner, Karl J Friston
Apr 25, 2006·Biostatistics·W Evan JohnsonAriel Rabinovic
Nov 23, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Christopher G GoetzNancy LaPelle
Sep 1, 2007·NeuroImage·John Ashburner
Sep 27, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Karin Stiasny-KolsterWolfgang H Oertel
May 4, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Gilles FénelonLaurent Cleret de Langavant
Sep 8, 2010·Movement Disorders : Official Journal of the Movement Disorder Society·Jacques MontplaisirJean Paquet
Jul 14, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Mélanie VendetteJean-François Gagnon
Oct 6, 2012·Neuro-degenerative Diseases·Angie A KehagiaTrevor W Robbins
Oct 23, 2012·Methods in Molecular Biology·Hervé Abdi, Lynne J Williams
Feb 14, 2013·Brain : a Journal of Neurology·Tao Wu, Mark Hallett
Mar 29, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Shady RahayelJean-François Gagnon
Mar 5, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Daniel WeintraubUNKNOWN Parkinson's Progression Markers Initiative
Oct 17, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Ronald B PostumaGünther Deuschl
Jun 15, 2016·Brain : a Journal of Neurology·Michal RolinskiMichele T M Hu
Jul 28, 2016·Brain : a Journal of Neurology·Lidia SarroKejal Kantarci
Aug 4, 2016·Alzheimer's Research & Therapy·Frederic BlancJohn-Paul Taylor
Jan 21, 2017·Nature Reviews. Neuroscience·D James SurmeierGlenda M Halliday
Apr 11, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Dillon McKenna, John Peever
May 19, 2017·PloS One·Chelsea Caspell-GarciaUNKNOWN Parkinson’s Progression Markers Initiative (PPMI)
Aug 23, 2017·NeuroImage·Jean-Philippe FortinRussell T Shinohara
Aug 27, 2017·Scientific Reports·Daniel RoquetFrédéric Blanc
Nov 21, 2017·NeuroImage·Jean-Philippe FortinRussell T Shinohara
Nov 25, 2017·Nature Reviews. Neurology·Birgit HöglAleksandar Videnovic
Apr 18, 2018·Annals of Neurology·Daphné Génier MarchandJean-François Gagnon
Dec 20, 2018·Annals of Clinical and Translational Neurology·Kenneth MarekUNKNOWN Parkinson's Progression Markers Initiative
Jan 9, 2019·Parkinsonism & Related Disorders·Pierre-Alexandre BourgouinJean-François Gagnon
Jan 15, 2019·International Review of Neurobiology·Pierre-Alexandre BourgouinJean-François Gagnon
Feb 23, 2019·Brain : a Journal of Neurology·Ronald B PostumaAmelie Pelletier
Mar 2, 2019·Journal of Neurology·Tayyabah YousafMarios Politis

❮ Previous
Next ❯

Citations

Jul 3, 2021·Nature Reviews. Disease Primers·Dag AarslandDaniel Weintraub

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.